Literature DB >> 22183439

Corticotropin-releasing factor: innocent until proven guilty.

William J Giardino, Andrey E Ryabinin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22183439      PMCID： PMC3365568          DOI： 10.1038/nrn3110-c1

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN： 1471-003X            Impact factor:   34.870


× No keyword cloud information.
  10 in total

Review 1.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

2.  Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2.

Authors:  Jan M Deussing; Johannes Breu; Claudia Kühne; Magdalena Kallnik; Mirjam Bunck; Lisa Glasl; Yi-Chun Yen; Mathias V Schmidt; Regine Zurmühlen; Annette M Vogl; Valérie Gailus-Durner; Helmut Fuchs; Sabine M Hölter; Carsten T Wotjak; Rainer Landgraf; Martin Hrabé de Angelis; Florian Holsboer; Wolfgang Wurst
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

3.  Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.

Authors:  J C Bittencourt; J Vaughan; C Arias; R A Rissman; W W Vale; P E Sawchenko
Journal:  J Comp Neurol       Date:  1999-12-20       Impact factor: 3.215

Review 4.  Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.

Authors:  Emily G Lowery; Todd E Thiele
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 5.  Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression.

Authors:  Johannes M H M Reul; Florian Holsboer
Journal:  Curr Opin Pharmacol       Date:  2002-02       Impact factor: 5.547

6.  The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol.

Authors:  A D Lê; S Harding; W Juzytsch; P J Fletcher; Y Shaham
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

7.  A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats.

Authors:  Cindy K Funk; George F Koob
Journal:  Brain Res       Date:  2007-04-10       Impact factor: 3.252

8.  Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice.

Authors:  Amanda L Sharpe; Tamara J Phillips
Journal:  Behav Pharmacol       Date:  2009-07       Impact factor: 2.293

9.  Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.

Authors:  M H Perrin; S W Sutton; L A Cervini; J E Rivier; W W Vale
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

10.  Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference.

Authors:  William J Giardino; Davelle L Cocking; Simranjit Kaur; Christopher L Cunningham; Andrey E Ryabinin
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240
  10 in total
  5 in total

1.  Differential sensitivity of alcohol drinking and partner preference to a CRFR1 antagonist in prairie voles and mice.

Authors:  Sheena Potretzke; Meridith T Robins; Andrey E Ryabinin
Journal:  Horm Behav       Date:  2020-01-13       Impact factor: 3.587

Review 2.  Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence.

Authors:  Jesse T Kaye; Daniel E Bradford; Katherine P Magruder; John J Curtin
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

3.  Increased alcohol consumption in urocortin 3 knockout mice is unaffected by chronic inflammatory pain.

Authors:  Monique L Smith; Ju Li; Andrey E Ryabinin
Journal:  Alcohol Alcohol       Date:  2014-12-01       Impact factor: 2.826

4.  CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption.

Authors:  William J Giardino; Andrey E Ryabinin
Journal:  Alcohol Clin Exp Res       Date:  2013-02-07       Impact factor: 3.455

5.  Control of chronic excessive alcohol drinking by genetic manipulation of the Edinger-Westphal nucleus urocortin-1 neuropeptide system.

Authors:  W J Giardino; E D Rodriguez; M L Smith; M M Ford; D Galili; S H Mitchell; A Chen; A E Ryabinin
Journal:  Transl Psychiatry       Date:  2017-01-31       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.